Catalyst Wire Dossier Catalyst Wire Dossier

MUCUS RELIEF DM

guaifenesin; dextromethorphan HBr · Dolgencorp, Inc. (Dollar General & Rexall)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MUCUS RELIEF DM, covering 2018-11-01 to 2018-11-01. Get the full timeline:

Most recent: FDA Approved: MUCUS RELIEF DM — Original Application (Dolgencorp, Inc. (DOLLAR GENERAL & REXALL))

See pricing